Click Here for 5% Off Your First Aladdin Purchase!

AKT Inhibitor VIII - ≥97%, high purity , CAS No.612847-09-3, Allosteric modulator of AKT serine/threonine kinase 1;Allosteric modulator of AKT serine/threonine kinase 2;Allosteric modulator of AKT serine/threonine kinase 3

  • ≥97%
Item Number
B304138
Grouped product items
SKUSizeAvailabilityPrice Qty
B304138-5mg
5mg
In stock
$129.90
B304138-25mg
25mg
In stock
$585.90
B304138-100mg
100mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$848.90

Potent isozyme selective Akt1/2 kinase inhibitor

Basic Description

SynonymsAkt inhibitor VIII|612847-09-3|Akti-1/2|YX4CPQ6V6X|Akt-I 1,2|1,3-Dihydro-1-(1-((4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one|1-(1-(4-(6-Phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)benzyl)-piperidin-4-yl)-1H-
Specifications & Purity≥97%
Storage TempStore at -20°C
Shipped InIce chest + Ice pads
Action TypeALLOSTERIC MODULATOR
Mechanism of actionAllosteric modulator of AKT serine/threonine kinase 1;Allosteric modulator of AKT serine/threonine kinase 2;Allosteric modulator of AKT serine/threonine kinase 3
Product Description

product description:

Akti-1/2 (Akt Inhibitor VIII) is a highly selective Akt1/Akt2 inhibitor with IC50 of 58 nM/210 nM, respectively, about 36-fold selectivity for Akt1 over Akt3. Akti-1/2 induces apoptosis.

Associated Targets

AKT3 Tchem RAC-gamma serine/threonine-protein kinase 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

AKT2 Tchem RAC-beta serine/threonine-protein kinase 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

AKT1 Tchem RAC-alpha serine/threonine-protein kinase 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name 3-[1-[[4-(6-phenyl-8H-imidazo[4,5-g]quinoxalin-7-yl)phenyl]methyl]piperidin-4-yl]-1H-benzimidazol-2-one
INCHI InChI=1S/C34H29N7O/c42-34-39-26-8-4-5-9-31(26)41(34)25-14-16-40(17-15-25)20-22-10-12-24(13-11-22)33-32(23-6-2-1-3-7-23)37-29-18-27-28(36-21-35-27)19-30(29)38-33/h1-13,18-19,21,25,38H,14-17,20H2,(H,39,42)
InChi Key IWCQHVUQEFDRIW-UHFFFAOYSA-N
Canonical SMILES C1CN(CCC1N2C3=CC=CC=C3NC2=O)CC4=CC=C(C=C4)C5=C(N=C6C=C7C(=NC=N7)C=C6N5)C8=CC=CC=C8
Isomeric SMILES C1CN(CCC1N2C3=CC=CC=C3NC2=O)CC4=CC=C(C=C4)C5=C(N=C6C=C7C(=NC=N7)C=C6N5)C8=CC=CC=C8
PubChem CID 135398501
Molecular Weight 551.66

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

2 results found

Lot NumberCertificate TypeDateItem
J2114042Certificate of AnalysisAug 09, 2024 B304138
J2114043Certificate of AnalysisAug 09, 2024 B304138

Chemical and Physical Properties

SensitivityLight sensitive ;Heat sensitive

Related Documents

References

1. Lindsley CW, Zhao Z, Leister WH, Robinson RG, Barnett SF, Defeo-Jones D, Jones RE, Hartman GD, Huff JR, Huber HE et al..  (2005)  Allosteric Akt (PKB) inhibitors: discovery and SAR of isozyme selective inhibitors..  Bioorg Med Chem Lett,  15  (3): (761-4).  [PMID:15664853]
2. Nagae K et al..  (2018)  Glucagon-like peptide-1 analogue liraglutide facilitates wound healing by activating PI3K/Akt pathway in keratinocytes..  Diabetes Res Clin Pract,  146  (155-161).  [PMID:30367901]
3. Tutunea-Fatan E et al..  (2015)  GRK2 targeted knock-down results in spontaneous hypertension, and altered vascular GPCR signaling..  J Biol Chem,  290  (8): (5141-55).  [PMID:25561731]
4. Lai Y et al..  (2016)  Inhibition of mTOR sensitizes breast cancer stem cells to radiation-induced repression of self-renewal through the regulation of MnSOD and Akt..  Int J Mol Med,  37  (2): (369-77).  [PMID:26707081]
5. Xu P et al..  (2022)  Hypoxia-mediated YTHDF2 overexpression promotes lung squamous cell carcinoma progression by activation of the mTOR/AKT axis..  Cancer Cell Int,  22  (13).  [PMID:34996459]
6. Naspi A et al..  (2017)  IGFBP-3 inhibits Wnt signaling in metastatic melanoma cells..  Mol Carcinog,  56  (2): (681-693).  [PMID:27377812]
7. Revu S et al..  (2018)  IL-23 and IL-1ß Drive Human Th17 Cell Differentiation and Metabolic Reprogramming in Absence of CD28 Costimulation..  Cell Rep,  22  (10): (2642-2653).  [PMID:29514093]
8. Sun H et al..  (2016)  Let-7 miRNAs sensitize breast cancer stem cells to radiation-induced repression through inhibition of the cyclin\xa0D1/Akt1/Wnt1 signaling pathway..  Mol Med Rep,  14  (4): (3285-92).  [PMID:27574028]
9. Wang Y et al..  (2017)  PI3K inhibitor LY294002, as opposed to wortmannin, enhances AKT phosphorylation in gemcitabine-resistant pancreatic cancer cells..  Int J Oncol,  50  (2): (606-612).  [PMID:28000865]
10. Foxall E et al..  (2019)  PAK4 Kinase Activity Plays a Crucial Role in the Podosome Ring of Myeloid Cells..  Cell Rep,  29  (11): (3385-3393.e6).  [PMID:31825823]
11. Cui J et al..  (2019)  Proteomic Identification of Pathways Responsible for the Estradiol Therapeutic Window in AD Animal Models..  Front Cell Neurosci,  13  (437).  [PMID:31680862]
12. Mao XQ et al..  (2022)  RNA-seq and ATAC-seq analyses of multilineage differentiating\xa0stress enduring\xa0cells: Comparison with dermal fibroblasts..  Cell Biol Int,  46  (9): (1480-1494).  [PMID:35673985]
13. Yang Y et al..  (2016)  The PDGF-BB-SOX7 axis-modulated IL-33 in pericytes and stromal cells promotes metastasis through tumour-associated macrophages..  Nat Commun,  (11385).  [PMID:27150562]
14. Tutunea-Fatan E et al..  (2015)  The role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis..  Mol Cancer,  14  (35).  [PMID:25744065]
15. Li N et al..  (2019)  The role of Zeb1 in the pathogenesis of morbidly adherent placenta..  Mol Med Rep,  20  (3): (2812-2822).  [PMID:31322233]
16. Meng C et al..  (2020)  White Spot Syndrome Virus Benefits from Endosomal Trafficking, Substantially Facilitated by a Valosin-Containing Protein, To Escape Autophagic Elimination and Propagate in the Crustacean Cherax quadricarinatus..  J Virol,  94  (24):   [PMID:32967962]

Solution Calculators